Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J. Ramus, Simon A. Gayther, Maria P. Intermaggio et al.|JNCI Journal of the National Cancer Institute|2015Cited by 441
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Veli‐Matti Kosma, Anja Rudolph et al.|Breast Cancer Research|2015Cited by 24
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumDieter Flesch‐Janys, Jieping Lei, Anja Rudolph et al.|Human Genetics|2015Cited by 10